Lactobacillus reuteri Colonisation of Extremely Preterm Infants in a Randomised Placebo-Controlled Trial

Lactobacillus reuteri DSM 17938 supplementation reduces morbidities in very low birth weight infants (<1500 g), while the effect on extremely low birth weight infants (ELBW, <1000 g) is still questioned. In a randomised placebo-controlled trial (ClinicalTrials.gov ID NCT01603368), head growth,...

Descripción completa

Detalles Bibliográficos
Autores principales: Spreckels, Johanne E., Wejryd, Erik, Marchini, Giovanna, Jonsson, Baldvin, de Vries, Dylan H., Jenmalm, Maria C., Landberg, Eva, Sverremark-Ekström, Eva, Martí, Magalí, Abrahamsson, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190634/
https://www.ncbi.nlm.nih.gov/pubmed/33923278
http://dx.doi.org/10.3390/microorganisms9050915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190634/
https://www.ncbi.nlm.nih.gov/pubmed/33923278
http://dx.doi.org/10.3390/microorganisms9050915

Ejemplares similares